• Ashley L Siegel, Cathy Bledsoe, Jesse Lavin, Francesca Gatti, Jonas Berge, Gregory Millman, Eric Turin, W Tyler Winders, John Rutter, Beniamino Palmeiri, and C George Carlson.
• Dept. of Physiology, Kirksville College of Osteopathic Medicine, AT Still University, Kirksville, MO 63501, USA.
• Neuromuscul. Disord. 2009 Feb 1; 19 (2): 131-9.

AbstractThe whole body tension (WBT) method was used to evaluate the hypothesis that long term treatment with NF-kappaB inhibitors improves the total forward pulling tension exerted by the limb musculature of the mdx mouse. Mdx mice exhibited significantly reduced WBT values and more profound weakening during the course of generating multiple forward pulling movements than age-matched nondystrophic mice. Long term treatment with the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) did not significantly reduce nuclear p65 activation in the costal diaphragm, but increased WBT by 12% in mature (12 month) mice. Daily treatment (30 days) of 1 month old mdx mice with the inhibitor ursodeoxycholic acid (UDCA) reduced costal diaphragm nuclear p65 activation by 40% and increased WBT by 21%. These results indicate that treatment with NF-kappaB inhibitors improves WBT in the mdx mouse and further establishes the utility of the WBT procedure in assessing therapeutic efficacy.

53 keywords...

hide…